What are some of the clinical considerations for healthcare professionals in prescribing antimicrobial drugs? Why don’t physicians invariably prescribe the antimicrobial with the largest zone of inhibition?
In addition, how does this relate to the resistance of pathogens to microbials and concerns about this phenomenon? Has this changed since the global pandemic of COVID-19? Have you witnessed these concerns in your professional career or personal life?
Links provided by instructor:
https://www.msn.com/en-in/news/world/antimicrobial-resistance-time-to-prioritize-sustainable-production-and-procurement-to-help-mitigate-amr/ar-AASekWO?ocid=BingNewsSearch&pfr=1
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://aspe.hhs.gov/sites/default/files/2021-09/aspe-antimicrobial-prescribing-during-covid.pdf
https://www.aafp.org/pubs/afp/issues/2001/0915/p999.html
Last Completed Projects
| topic title | academic level | Writer | delivered |
|---|